跳至主要内容
临床试验/CTRI/2012/12/003273
CTRI/2012/12/003273招募中未知

A open label, randomized controlled trial of Artesunate Sulfadoxine- Pyrimethamine (AS-SP) vs Artesunate - Sulfadoxine-Pyrimethamine + Primaquine (AS-SP+PQ) for decreasing malaria transmission in India - ACT+PQ

ational Institute of Malaria Research New Delhi0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Open enrollment of any uncomplicated PF patient regardless of the gametocyte status, including mixed infections. This provides a stronger trial design given the operational simplicity, fewer assumptions, and greater generalizability of results

排除标准

  • Signs of severe malaria, history of previous antimalarial intake within < 1 week, children <1 year, and G6PD deficient patients will be excluded from the study.

研究者

发起方
ational Institute of Malaria Research New Delhi

相似试验